arabinofuranosyluracil has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehninger, G; Hiddemann, W; Illmer, T; Karsch, C; Kiani, A; Lindner, LH; Ostermann, H; Platzbecker, U; Schleyer, E; Würfel, M | 1 |
| Cain, M; Cull, GM; Hackett, LP; Ilett, KF; Radeski, D | 1 |
2 other study(ies) available for arabinofuranosyluracil and Encephalopathy, Toxic
| Article | Year |
|---|---|
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.
Topics: Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Cytarabine; Female; Half-Life; Humans; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Male; Middle Aged; Neurotoxicity Syndromes | 2008 |
Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Female; Humans; Kidney Failure, Chronic; Lymphoma, Mantle-Cell; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis | 2011 |